Cavernous cerebral infarction is called cavernous cerebral infarction, which is not a serious disease and generally has a better prognosis, but the occurrence of cavernous cerebral infarction can indicate that the patient’s state of cerebrovascular lesions is poorer, and there is a risk of reoccurrence of the second cerebral infarction, so it is still necessary to pay attention to it. Cavernous cerebral infarction is an ischemic micro-infarction occurring in the deep penetrating arteries of the brain, which belongs to small artery occlusion cerebral infarction, and the patients mostly have hypertension, diabetes mellitus, hyperlipidemia and other underlying diseases, and after the onset of the disease, they may have symptoms such as mild hemiparesis, dizziness, memory loss, etc. Generally, these symptoms can be relieved after the treatment. For treatment, drugs such as nifedipine can be used to control blood pressure, insulin, metformin and other drugs can be used to control blood glucose, simvastatin and other drugs can be used to regulate blood lipids, mannitol, glycerol fructose and other drugs can be used to dehydrate and lower the cranial pressure, thrombolysis can be used with urokinase and other drugs, and anti-platelet aggregation can be used with aspirin and clopidogrel and other drugs. Although cavernous cerebral infarction has a good prognosis and low mortality and disability rates, it is prone to recurrent episodes, therefore, if diagnosed with cavernous cerebral infarction, please follow the doctor’s instructions for treatment.